AnaptysBio appoints Christopher Murphy CFO ($42,917/mo) and Owen Hughes to board

ANAPTYSBIO, INC

Christopher Murphy appointed CFO effective May 11, 2026; previously CFO at Third Harmonic Bio and Horizon Therapeutics.
Murphy's consulting agreement: $42,916.66 monthly fee, target bonus up to 40% of annual fees, and $1.75M RSU grant vesting over 4 years.
Owen Hughes appointed Class I director effective May 11, 2026; receives initial grant of 11,250 RSUs vesting over 3 years.
Murphy serves as independent contractor; severance provides 9-12 months fee continuation based on termination cause.

item 5.02

Source: SEC EDGAR

accession 0001193125-26-216745

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.